Published by Frank Prenesti on 8th April 2024
(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.
URL: http://www.digitallook.com/dl/news/story/34204900/...